{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:10:58Z","timestamp":1794269458183,"version":"4.9.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["82011540409"],"award-info":[{"award-number":["82011540409"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373952"],"award-info":[{"award-number":["82373952"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204502"],"award-info":[{"award-number":["82204502"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.taap.2024.117064","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:16:54Z","timestamp":1723076214000},"page":"117064","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach"],"prefix":"10.1016","volume":"491","author":[{"given":"Qingfeng","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiying","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aole","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Gook","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker M.","family":"Lauschke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqiang","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0005","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/toxsci\/kfy191","article-title":"Using quantitative systems toxicology to investigate observed species differences in CKA-mediated hepatotoxicity","volume":"166","author":"Battista","year":"2018","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2024.117064_bb0015","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cotox.2017.07.003","article-title":"Quantitative systems toxicology","volume":"4","author":"Bloomingdale","year":"2017","journal-title":"Curr. Opin. Toxicol."},{"key":"10.1016\/j.taap.2024.117064_bb0020","first-page":"1","article-title":"Current practices for QSP model assessment: an IQ consortium survey","author":"Chan","year":"2022","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.taap.2024.117064_bb0025","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0030","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10047","key":"10.1016\/j.taap.2024.117064_bb0035","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S0140-6736(16)00278-6","article-title":"Hyperthyroidism","volume":"388","author":"De Leo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.taap.2024.117064_bb0040","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ddtec.2016.11.001","article-title":"Quantitative systems pharmacology: a promising approach for translational pharmacology","volume":"21-22","author":"Gadkar","year":"2016","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.taap.2024.117064_bb0045","series-title":"Overcoming Obstacles in Drug Discovery and Development","first-page":"107","article-title":"Chapter 8 - how to reduce risk of drug induced liver toxicity from the beginning","author":"Gan","year":"2023"},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2020.100245","article-title":"Measurement of mitochondrial respiration in adherent cells by seahorse XF96 cell Mito stress test","volume":"2","author":"Gu","year":"2021","journal-title":"STAR Protoc."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0055","first-page":"1","article-title":"An overview on the proposed mechanisms of antithyroid drugs-induced liver injury","volume":"5","author":"Heidari","year":"2015","journal-title":"Adv. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.taap.2024.117064_bb0060","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s10928-012-9266-0","article-title":"In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym: a mechanistic, mathematical model of DILI","volume":"39","author":"Howell","year":"2012","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0065","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1111\/bcpt.13284","article-title":"Association between genetic polymorphisms of SLCO1B1 and susceptibility to methimazole-induced liver injury","volume":"125","author":"Jin","year":"2019","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0070","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/toxsci\/kfj095","article-title":"Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone","volume":"90","author":"Kostrubsky","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"15","key":"10.1016\/j.taap.2024.117064_bb0075","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1001\/jama.2023.19052","article-title":"Hyperthyroidism: a review","volume":"330","author":"Lee","year":"2023","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.taap.2024.117064_bb0080","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/jpet.106.119073","article-title":"Differential inhibition of rat and human Na+\u2212dependent taurocholate cotransporting polypeptide (NTCP\/SLC10A1)by bosentan: a mechanism for species differences in hepatotoxicity","volume":"321","author":"Leslie","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.117064_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109095","article-title":"Association of HLA-C*03:02 with methimazole-induced liver injury in Graves\u2019 disease patients","volume":"117","author":"Li","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0090","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00204-019-02618-z","article-title":"Mechanistic examination of methimazole-induced hepatotoxicity in patients with Grave\u2019s disease: a metabolomic approach","volume":"94","author":"Li","year":"2020","journal-title":"Arch. Toxicol."},{"issue":"11","key":"10.1016\/j.taap.2024.117064_bb0095","doi-asserted-by":"crossref","DOI":"10.3390\/ph14111194","article-title":"Simultaneous quantification of Propylthiouracil and its N-beta-d glucuronide by HPLC-MS\/MS: application to a metabolic study","volume":"14","author":"Li","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"10.1016\/j.taap.2024.117064_bib236","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00204-021-03023-1","article-title":"Prediction of oral hepatotoxic dose of natural products derived from traditional Chinese medicines based on SVM classifier and PBPK modeling","volume":"95","author":"Li","year":"2021","journal-title":"Arch. Toxicol."},{"issue":"12","key":"10.1016\/j.taap.2024.117064_bb0100","first-page":"788","article-title":"Applications of in silico models to predict drug-induced liver injury","volume":"10","author":"Lin","year":"2022"},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0105","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/s42003-020-0988-z","article-title":"High-content fluorescence imaging with the metabolic flux assay reveals insights into mitochondrial properties and functions","volume":"3","author":"Little","year":"2020","journal-title":"Commun. Biol."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0110","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/psp4.12053","article-title":"Elucidating differences in the hepatotoxic potential of Tolcapone and Entacapone with DILIsym((R)), a mechanistic model of drug-induced liver injury","volume":"5","author":"Longo","year":"2016","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0115","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1093\/toxsci\/kfy253","article-title":"Quantitative systems toxicology analysis of in vitro mechanistic assays reveals importance of bile acid accumulation and mitochondrial dysfunction in TAK-875-induced liver injury","volume":"167","author":"Longo","year":"2019","journal-title":"Toxicol. Sci."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0120","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/toxsci\/kfaa019","article-title":"Assessing effects of BHV-0223 40 mg Zydis sublingual formulation and Riluzole 50 mg Oral tablet on liver function test parameters utilizing DILIsym","volume":"175","author":"Longo","year":"2020","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2024.117064_bb0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jchromb.2014.07.016","article-title":"Propylthiouracil quantification in human plasma by high-performance liquid chromatography coupled with electrospray tandem mass spectrometry: application in a bioequivalence study","volume":"969","author":"Mendes","year":"2014","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"issue":"4","key":"10.1016\/j.taap.2024.117064_bb0130","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/cpt.564","article-title":"Drug-induced liver injury: advances in mechanistic understanding that will inform risk management","volume":"101","author":"Mosedale","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0135","first-page":"275","article-title":"Considerations for physiologically based modeling in liver disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)","volume":"113","author":"Murphy","year":"2023"},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0140","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1210\/jc.2006-2135","article-title":"Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves\u2019 disease","volume":"92","author":"Nakamura","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0145","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/jcph.1378","article-title":"Physiologically based pharmacokinetic modeling approach to predict drug-drug interactions with Ethionamide involving impact of genetic polymorphism on FMO3","volume":"59","author":"Nguyen","year":"2019","journal-title":"J. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.taap.2024.117064_bb0150","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1111\/bcp.14684","article-title":"Investigating the interaction between nifedipine- and ritonavir-containing antiviral regimens: a physiologically based pharmacokinetic\/pharmacodynamic analysis","volume":"87","author":"Niu","year":"2021","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"10","key":"10.1016\/j.taap.2024.117064_bb0155","doi-asserted-by":"crossref","DOI":"10.21769\/BioProtoc.2850","article-title":"Measurement of oxygen consumption rate (OCR) and extracellular acidification rate (ECAR) in culture cells for assessment of the energy metabolism","volume":"8","author":"Plitzko","year":"2018","journal-title":"Bio-Protoc."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0160","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4254\/wjh.v9.i1.30","article-title":"Drug-induced liver injury: towards early prediction and risk stratification","volume":"9","author":"Raschi","year":"2017","journal-title":"World J. Hepatol."},{"issue":"12","key":"10.1016\/j.taap.2024.117064_bb0165","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/jps.2600721211","article-title":"Bioavailability of propylthiouracil in humans","volume":"72","author":"Ringhand","year":"1983","journal-title":"J. Pharm. Sci."},{"issue":"10","key":"10.1016\/j.taap.2024.117064_bb0170","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and Management of Hyperthyroidism and Other Causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"issue":"8","key":"10.1016\/j.taap.2024.117064_bb0175","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1007\/s11095-022-03295-x","article-title":"Applications of quantitative systems pharmacology (QSP) in drug development for NAFLD and NASH and its regulatory application","volume":"39","author":"Siler","year":"2022","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/toxsci\/kfaa093","article-title":"Mechanistic investigations support liver safety of Ubrogepant","volume":"177","author":"Smith","year":"2020","journal-title":"Toxicol. Sci."},{"issue":"8","key":"10.1016\/j.taap.2024.117064_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2023.103642","article-title":"Perspectives of data science in preclinical safety assessment","volume":"28","author":"Steger-Hartmann","year":"2023","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.taap.2024.117064_bb0190","doi-asserted-by":"crossref","DOI":"10.1038\/psp.2014.40","article-title":"Implementation of quantitative and systems pharmacology in large pharma","volume":"3","author":"Visser","year":"2014","journal-title":"CPT Pharmacometrics Syst. Pharmacol."},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0195","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/clpt.2011.63","article-title":"Drug safety sciences and the bottleneck in drug development","volume":"89","author":"Watkins","year":"2011","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0200","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/cts.12629","article-title":"The DILI-Sim initiative: insights into hepatotoxicity mechanisms and biomarker interpretation","volume":"12","author":"Watkins","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.taap.2024.117064_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cotox.2020.06.003","article-title":"DILIsym: quantitative systems toxicology impacting drug development","volume":"23-24","author":"Watkins","year":"2020","journal-title":"Curr. Opin. Toxicol."},{"issue":"4","key":"10.1016\/j.taap.2024.117064_bb0210","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-8587(23)00005-0","article-title":"Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis","volume":"11","author":"Wiersinga","year":"2023","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"1","key":"10.1016\/j.taap.2024.117064_bb0215","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfw193","article-title":"Application of a mechanistic model to evaluate putative mechanisms of Tolvaptan drug-induced liver injury and identify patient susceptibility factors","volume":"155","author":"Woodhead","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"3","key":"10.1016\/j.taap.2024.117064_bb0220","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s11095-019-2582-y","article-title":"Analyzing the mechanisms behind macrolide antibiotic-induced liver injury using quantitative systems toxicology modeling","volume":"36","author":"Woodhead","year":"2019","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.taap.2024.117064_bb0225","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1007\/s11095-014-1591-0","article-title":"MITOsym(R): a mechanistic, mathematical model of hepatocellular respiration and bioenergetics","volume":"32","author":"Yang","year":"2015","journal-title":"Pharm. Res."},{"issue":"2","key":"10.1016\/j.taap.2024.117064_bb0230","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4158\/EP-2019-0221","article-title":"Side effects of Ptu and mmi in the treatment of hyperthyroidism: a systematic review and Meta-analysis","volume":"26","author":"Yu","year":"2020","journal-title":"Endocr. Pract."},{"issue":"5","key":"10.1016\/j.taap.2024.117064_bb0235","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj1954.33.605","article-title":"Pharmacokinetics of Methimazole in Normal subjects and hyperthyroid patients","volume":"33","author":"Yukari Okamura","year":"1986","journal-title":"Endocrinol. Japon."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2400262X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X2400262X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T00:26:10Z","timestamp":1725841570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X2400262X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":48,"alternative-id":["S0041008X2400262X"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.117064","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of drug-induced liver injury risk between propylthiouracil and methimazole: A quantitative systems toxicology approach","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.117064","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117064"}}